Rocket Pharmaceuticals (RCKT) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.62
-0.55
-0.48
-0.41

Details

Expected EPS
-0.406785
Actual EPS
-0.42
Surprise EPS
-0.01
Surprise Percent
+3.25%

Description

Rocket Pharmaceuticals (RCKT) has reported earnings of -0.42 per share for Q2 2026.

0 Comments

Share your thoughts